New Head of Analytics to Help Healthcare Target Interventions for Better Outcomes

MedeAnalyticsA new head of analytics at the UK arm of MedeAnalytics, a pioneer in health analytics, is to help healthcare planners and frontline staff understand which patients, across their entire local population, are at risk of specific adverse events and what interventions will work for individual patients as a means of prevention.

Paul Molyneux, who has held posts at the Care Quality Commission (CQC), Cerner and Dr Foster, has joined a rapidly growing team of world-class specialists at MedeAnalytics in the UK. Working with areas like Hertfordshire, the team has helped health and social care organisations overcome information governance obstacles to create a joined-up health economy. The result is that for the first time, organisations can safely link and unlock their data for use across health and social care whilst still securely maintaining patient privacy.

Molyneux, who was once part of the Healthcare Commission team that uncovered statistical outliers related to the Mid Staffordshire scandal, will now work closely with clinical and epidemiological colleagues at MedeAnalytics and throughout health and care.

He will help to develop risk models that predict which interventions will prove successful for specific patients and that will allow resources to be targeted where they will work across populations.

Commenting on his appointment Molyneux said: "If you can measure something, you can manage it. MedeAnalytics has become the first to solve major governance obstacles to enable the safe sharing and use of information between authorised users across different care settings. I look forward to working with customers throughout the UK to help them unleash the power of that information by predicting where and when, across their health economy, they can have the maximum impact for patients. Crucially, this is about getting research onto the shop floor and into practice, in order to improve outcomes."

Molyneux's new role at MedeAnalytics follows a series of high profile appointments in the UK for the company, including Professor Simon Jones, former chief statistician at Dr Foster, and Dr Mark Davies, the former medical director at the Health and Social Care Information Centre.

Wayne Parslow, UK general manager at MedeAnalytics, said: "Having the right people in place with the right tools to respond to real NHS and healthcare challenges is crucial. Paul will work closely with Professor Jones and Dr Davies to hone new ideas on predictive analytics, with real clinical understanding, so that we can help local health economies deliver services that are truly focussed on achieving the most for individual patients across their population. This will herald a new era of targeted and more efficient health and social care.

"Combining these thought leaders, with the right technology, and working in collaboration with those on the frontline, will allow the NHS and social care to not only understand which patients are at risk, but where, when and how they can successfully intervene."

About MedeAnalytics
MedeAnalytics provides evidence-based insights to solve a real problem that plagues healthcare - how to use the immense amount of patient data collected along the care continuum to deliver cost-effective care and promote a healthier population. Its analytics platform delivers intelligence that helps healthcare organizations detect their greatest areas of risk and identify opportunities to improve their financial health. It empowers providers and health plans to collaborate and use data to strengthen their operations and improve the quality of care. MedeAnalytics' cloud-based tools have been used to uncover business insights for nearly 1,000 healthcare organizations across the United States and United Kingdom. The company has also been named one of Modern Healthcare's top 100 Best Places to Work in Healthcare for 2014.

Most Popular Now

European Artificial Intelligence Act Com…

The European Artificial Intelligence Act (AI Act), the world's first comprehensive regulation on artificial intelligence, enters into force. The AI Act is designed to ensure that AI developed and used...

Patient Safety must be Central to the De…

An EPR system brings together different patient information in one place, making it easier to access for healthcare professionals. This information can include patients' own notes, test results, observations by...

ChatGPT Shows Promise in Answering Patie…

The groundbreaking ChatGPT chatbot shows potential as a time-saving tool for responding to patient questions sent to the urologist's office, suggests a study in the September issue of Urology Practice®...

Survey: Most Americans Comfortable with …

Artificial intelligence (AI) is all around us - from smart home devices to entertainment and social media algorithms. But is AI okay in healthcare? A new national survey commissioned by...

AI Spots Cancer and Viral Infections at …

Researchers at the Centre for Genomic Regulation (CRG), the University of the Basque Country (UPV/EHU), Donostia International Physics Center (DIPC) and the Fundación Biofisica Bizkaia (FBB, located in Biofisika Institute)...

Video Gaming Improves Mental Well-Being

A pioneering study titled "Causal effect of video gaming on mental well-being in Japan 2020-2022," published in Nature Human Behaviour, has conducted the most comprehensive investigation to date on the...

New Diabetes Research Links Blood Glucos…

As part of its ongoing exploration of vocal biomarkers and the role they can play in enhancing health outcomes, Klick Labs published a new study in Scientific Reports - confirming...

Machine learning helps identify rheumato…

A machine-learning tool created by Weill Cornell Medicine and Hospital for Special Surgery (HSS) investigators can help distinguish subtypes of rheumatoid arthritis (RA), which may help scientists find ways to...

New AI Software could Make Diagnosing De…

Although Alzheimer's is the most common cause of dementia - a catchall term for cognitive deficits that impact daily living, like the loss of memory or language - it's not...

A New AI Tool for Cancer

Scientists at Harvard Medical School have designed a versatile, ChatGPT-like AI model capable of performing an array of diagnostic tasks across multiple forms of cancers. The new AI system, described Sept...

Vision-Based ChatGPT Shows Deficits Inte…

Researchers evaluating the performance of ChatGPT-4 Vision found that the model performed well on text-based radiology exam questions but struggled to answer image-related questions accurately. The study's results were published...

Bayer Launches New Healthy-Aging Ecosyst…

Combining a scientifically formulated dietary supplement, a leading-edge wellness companion app, and a saliva-based a biological age test by Chronomics, Bayer is taking a big step in the emerging healthy-aging...